Novavax, Inc.

NVAX·NasdaqGS·Healthcare
Compare
10.65+0.97 (+10.02%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market10.66+0.01 (+0.09%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close9.68
Open10.01
Day range9.8410.67
52-week range6.2013.39
Off day high−0.19%
Off 52-week high−20.46%
Volume5.96M
Avg. volume (3M)6.39M
Market cap1.76B
EPS (TTM)-1.58
Forward P/E-64.97
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.72
Shares outstanding164.95M
Short interest28.89% of float
Earnings dateNov 5, 2026
Analyst target14.44
Profit margin−59.87%

Against its peers

Compare in full ›
NVAX PCVX VIR NVCT VALN 1873.HK
Market cap 1.76B 10.34B 1.99B 602.94M 533.86M 2.80B
P/E (TTM) — — — — — 16.9
Forward P/E -65.0 -9.2 -4.8 -19.2 4.7 6.2
Price/book -9.2 3.2 2.1 5.1 5.9 0.6
Dividend yield — — — — — —
1-year change +40.32% +57.47% +129.88% +225.75% −36.74% −43.17%
Today +10.02% +8.01% +4.90% −4.50% +2.18% +5.04%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Novavax's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Vaxcyte, Inc.PCVX · Biotechnology 10.34B 65.68 +8.01%
Vir Biotechnology, Inc.VIR · Biotechnology 1.99B 11.77 +4.90%
Nuvectis Pharma, Inc.NVCT · Biotechnology 602.94M 18.47 −4.50%
Valneva SEVALN · Biotechnology 533.86M 5.63 +2.18%
Viva Biotech Holdings1873.HK · Biotechnology 2.80B 1.355 +5.04%
Atea Pharmaceuticals, Inc.AVIR · Biotechnology 357.71M 4.4600 +6.95%
Bavarian Nordic A/SBAVA.CO · Biotechnology 18.62B 249.60 +1.13%
REGENXBIO Inc.RGNX · Biotechnology 508.96M 7.71 +1.05%

Also based in Gaithersburg, Maryland, then elsewhere in Maryland.

Company Mkt cap Price Today
Altimmune, Inc.ALT · Gaithersburg, MD 412.38M 2.1200 +3.92%
Emergent BioSolutions Inc.EBS · Gaithersburg, MD 303.35M 5.90 −5.60%
Elutia Inc.ELUT · Gaithersburg, MD 33.64M 0.7596 −6.59%
Shuttle Pharmaceuticals Holdings, Inc.SHPH · Gaithersburg, MD 24.82M 5.21 +1.17%
Bullfrog AI Holdings, Inc.BFRG · Gaithersburg, MD 9.76M 0.5263 +0.59%
20/20 Biolabs, Inc.AIDX · Gaithersburg, MD 2.92M 0.2289 −2.55%
Lockheed Martin CorporationLMT · Bethesda, MDOdds 137.46B 595.04 −6.88%
Marriott International, Inc.MAR · Bethesda, MDOdds 109.41B 424.87 +2.04%

The stocks whose daily moves over the past year went most closely with Novavax's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Moderna, Inc.MRNA · Correlation 0.59Odds 103.15B 258.38 +13.11%
Vaxcyte, Inc.PCVX · Correlation 0.46 10.34B 65.68 +8.01%
BioNTech SEBNTX · Correlation 0.43 22.49B 90.70 +4.35%
Intellia Therapeutics, Inc.NTLA · Correlation 0.43 1.72B 12.31 +3.79%
Vir Biotechnology, Inc.VIR · Correlation 0.40 1.99B 11.77 +4.90%
Emergent BioSolutions Inc.EBS · Correlation 0.40 303.35M 5.90 −5.60%
Absci CorporationABSI · Correlation 0.36 1.80B 10.48 +4.80%
Stoke Therapeutics, Inc.STOK · Correlation 0.34 1.78B 27.45 +1.70%

What visitors to Novavax's page also look at.

Company Mkt cap Price Today
Moderna, Inc.MRNAOdds 103.15B 258.38 +13.11%
Inovio Pharmaceuticals, Inc.INO 167.50M 1.6200 −2.41%
BioNTech SEBNTX 22.49B 90.70 +4.35%
Vaxart, Inc.VXRT 97.48M 0.4000 0.00%
AstraZeneca PLCAZN 293.14B 189.01 +2.79%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All NVAX news ›
StockStory·Positive

Novavax (NVAX) reports earnings tomorrow: what to expect

Vaccine biotechnology company Novavax (NASDAQ:NVAX) will be reporting earnings this Thursday before market hours. Here’s what you need to know. Novavax beat analysts’ revenue expectations last quarter, reporting revenues of $56.7 million,…

NVAXNVSSPCX
AOL.com··2 outletsPositive

Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe

Novavax (Nasdaq: NVAX) has earned a $125 million milestone payment with the initiation (fifth patient dosed) of Sanofi's Phase 3 influenza-COVID-19 combination vaccine trial utilizing Novavax's ... The global flu and COVID-19 markets have…

NVAXPFEMRNASNY
More from 1 other outlet

From the 4Search news index, newest first.

In the news

46mentions in 30 days
38with it in the headline
Positivesentiment

Mentioned with

Novavax, Inc28Sanofi28Novavax, Inc.26Novartis25Pfizer23Moderna22Novo Nordisk20Eli Lilly14

People in the coverage

Moderna37Mitch Edgeman28Keytruda19Kim Johansen12Sarita Garza12Robert Half11

Themes

Healthcare24Health16Moderna16Mrna13Biotechnology11Cancer Vaccine8Melanoma8Moderna Stock8

Most coverage from

  1. themarketsdaily.com6
  2. 247wallst.com5
  3. pluang.com3
  4. theglobeandmail.com3
  5. aol.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 46 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance